comprehensive -WSS

comprehensive

author：fashion 2025-10-01 15:29:27 - browse：7931

Senator Ron Wyden (D-OR) speaks with reporters in the Senate subway at the U.S. Capitol — Sen. Ron Wyden (D-Ore.) Drew Angerer/Getty Images

Senate Finance Committee members from both parties took aim Wednesday at insurance brokers that sell plans for large Medicare Advantage insurers.

Older adults at times have more than 100 plan options, and brokers help them choose the right one. But brokers can be incentivized by large insurance companies to aggressively sell plans that are a poor fit for the Medicare beneficiaries they’re supposed to help. Brokers also sometimes collect private information that they sell to multiple insurance companies. Those brokers tend to have a national scope, just like the large insurers they represent, compared to the independent, local brokers.

“They are big private marketing companies in the middle between seniors and their coverage,” Chairman Ron Wyden (D-Ore.) said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： State Dept. review finds Biden bears some blame for Afghanistan failures
Next article： Sweden knocks USA out of World Cup in penalty kicks

WSS

Roivant's CEO is a star, but biotech's black hole persists

Election results set back Medicaid expansion plans

Is there really a nursing shortage in the U.S.?

Many breast cancer patients receive more radiation than needed

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

focus

comprehensive

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Roivant's CEO is a star, but biotech's black hole persists

State Dept. review finds Biden bears some blame for Afghanistan failures

Harvard's Jason Buenrostro wins MacArthur grant for genetics work

Activists slam private health insurers over coverage restrictions

Doctors push to include dialysis machines in emergency stockpile

Apple is now the first public company to be valued at $3 trillion

The problems with dementia villages

Wildfire smoke exposes gaps in outdoor worker protections

'Brian's Song' at 50 still offers lessons about cancer for today

focus

Paxlovid rebound happens. Why and to whom are still a mystery

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Doctors are clamoring for more clarity on Paxlovid prescribing

Merck, Daiichi strike cancer drug pact worth up to $22 billion

Readout Newsletter: AstraZeneca's CEO, Roivant's $5 billion deal

focus

Wikipedia

hotspot

focus